Skip to main content
GNOM logo
GNOM
(NASDAQ)
Global X Genomics & Biotechnology ETF
$63.57-- (--)
Loading... - Market loading

GNOM ETF: Global X Genomics & Biotechnology ETF - Price, Holdings & Analysis

Global X Genomics & Biotechnology ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$63.59 - $64.61
52-Week High$68.00
52-Week Low$36.00
Open$64.61
Volume52.74K
Average Volume (3M)25.91K
Assets (AUM)78.81M
Expense Ratio0.50%
Total Holdings51
Inception DateApr 5, 2019
1 Day Change-1.09%
1 Month Change14.09%
6 Month Change40.40%
YTD Change40.72%
1 Year Change69.15%
52-Week Change69.15%
5 Year Change-35.27%
50-Day MA$58.92
200-Day MA$49.67
RSI57.06
Stochastic %K61.12
Stochastic %D69.01
Annual Dividend$0.68
Dividend Yield1.06%
Last Dividend Ex-DateJan 7, 2027
Dividend Growth YoY1959.84%

Frequently Asked Questions About Global X Genomics & Biotechnology ETF

What is the current price of GNOM?

The latest GNOM price is $64.26. The 52-week range is $36.00–$68.00. GNOM has returned 69.1% over the past 52 weeks.

What is the expense ratio for GNOM?

GNOM's annual expense ratio is 0.50%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does GNOM pay dividends?

Yes, GNOM pays a 1.06% dividend yield. The last ex-dividend date was 2027-01-07. View full dividend history in the Dividends section.

What are the top holdings of GNOM?

GNOM's largest holdings are Guardant Health, Inc (5.8%), Legend Biotech Corporation (5.4%), Illumina, Inc. (5.3%) (combined weight: 16.6%). The fund holds 51 total positions. View the complete portfolio breakdown in the Holdings section.

How does GNOM compare to similar ETFs?

Compare GNOM (0.50% expense ratio, $79M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.